447 results
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
of the meeting. Meetings of stockholders for any other purpose may be held at such time and place, within or without the State of Delaware, as shall … ) of the General Corporation Law of Delaware.
Section 2. Annual Meeting. The annual meeting of the stockholders of the corporation, for the purpose
S-8
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
10 Aug 22
Registration of securities for employees
4:05pm
)Estimated in accordance with Rule 457(c) and Rule 457(h) under the Securities Act solely for the purpose of calculating the registration fee … for the purpose of calculating the registration fee. The proposed maximum offering price per share is $89.70 per share, which is the weighted-average
S-4
EX-3.3
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Jul 98
Registration of securities issued in business combination transactions
12:00am
of stockholders for any other purpose may be
held at such time and place, within or without the State of Delaware, as shall
be stated in the notice … of the stockholders of the
corporation, for the purpose of election of Directors and for such other
business as may lawfully come before it, shall be held
425
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
23 Mar 22
Business combination disclosure
5:29pm
announced the signing of a definitive merger agreement with Avista Public Acquisition Corp. II (APAC) (NASDAQ: AHPA), a publicly traded special purpose … , please visit www.omniab.com.
About Avista Public Acquisition Corp. II
APAC is a special purpose acquisition company that completed its initial public
8-K
EX-4
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 06
Entry into a Material Definitive Agreement
12:00am
fide
public offering of securities) for the purpose of acquiring, holding, voting
(except to the extent contemplated by the proviso to Section 1(c)(ii … is part of a plan,
arrangement or understanding which has as a primary purpose or effect avoidance
of Section 7(e) hereof, and any Rights Certificate
S-8
u2jva8q3ggdha
5 Jul 12
Registration of securities for employees
12:00am
8-K
EX-3.1
zgbchv7wbow21k02b
30 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:07pm
S-8
czkv6
1 Mar 24
Registration of securities for employees
4:09pm
SC TO-T
iwyayfthml5 gc2m
31 Aug 20
Third party tender offer statement
8:46am
S-8
7mgd3h5v uds3
27 Jan 21
Registration of securities for employees
4:58pm
8-K
EX-10.3
jndaodz042x
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-A12B
EX-4
4nrrqabf ib570
17 Oct 06
Registration of securities on exchange
12:00am
8-A12G/A
EX-4.1
jrtumj85n3y3prhsefb
6 Apr 04
Registration of securities (amended)
12:00am
S-8
eshzs47uucoqmp
13 Jun 22
Registration of securities for employees
8:44am
425
u3tp9tbmunhv
3 Oct 22
Business combination disclosure
9:20am
8-K
EX-99.1
h9j0yq
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
S-3/A
EX-10.1
4x8tzgt3zvljft
22 Oct 96
Shelf registration (amended)
12:00am
8-K
EX-3.1
iqp5i9d8z16nq
12 Apr 13
Amendments to Articles of Incorporation or Bylaws
12:00am